Engineers Gate Manager’s AbCellera Biologics ABCL Stock Holding History

Engineers Gate Manager’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-181,472	Closed	-$633K	–	2193
2026 Q1	$633K	Buy	181,472 +170,269	+1,520%	+$613K	0.01%	1266
2025 Q4	$38.3K	Buy	+11,203	New	+$50K	﹤0.01%	1997
2024 Q3	–	Sell	-30,761	Closed	-$91.1K	–	2068
2024 Q2	$91.1K	Buy	+30,761	New	+$116K	﹤0.01%	1760
2023 Q3	–	Sell	-51,445	Closed	-$332K	–	1741
2023 Q2	$332K	Buy	+51,445	New	+$351K	0.01%	1263
2023 Q1	–	Sell	-74,105	Closed	-$751K	–	1605
2022 Q4	$751K	Sell	74,105 -4,144	-5%	-$47.9K	0.05%	647
2022 Q3	$774K	Buy	+78,249	New	+$859K	0.05%	559

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Engineers Gate Manager's ABCL Position: Q2 2026 in Review

Engineers Gate Manager sold out of AbCellera Biologics (ABCL) in Q2 2026, closing a stake of 181,472 shares — an estimated $633K sold.

Engineers Gate Manager first reported a position in ABCL in Q3 2022 and held it in 6 quarters. The position peaked at $774K in Q3 2022. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

Engineers Gate Manager reported no remaining AbCellera Biologics position as of Q2 2026 after selling out during the quarter.
Engineers Gate Manager sold 181,472 AbCellera Biologics shares in Q2 2026, an estimated $633K.
Engineers Gate Manager first reported a position in AbCellera Biologics in Q3 2022 and held it in 6 quarters.
Engineers Gate Manager's AbCellera Biologics position peaked at $774K in Q3 2022.
151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.